17-17221311-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000389169.9(FLCN):c.*68G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.13 in 1,552,526 control chromosomes in the GnomAD database, including 14,040 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 979 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13061 hom. )
Consequence
FLCN
ENST00000389169.9 3_prime_UTR
ENST00000389169.9 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.545
Publications
9 publications found
Genes affected
FLCN (HGNC:27310): (folliculin) This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
FLCN Gene-Disease associations (from GenCC):
- Birt-Hogg-Dube syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- Birt-Hogg-Dube syndrome 1Inheritance: AD Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
- familial spontaneous pneumothoraxInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- renal carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- colorectal cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-17221311-C-T is Benign according to our data. Variant chr17-17221311-C-T is described in ClinVar as Benign. ClinVar VariationId is 1266988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.137 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FLCN | ENST00000389169.9 | c.*68G>A | 3_prime_UTR_variant | Exon 8 of 8 | 1 | ENSP00000373821.5 | ||||
| FLCN | ENST00000285071.9 | c.871+226G>A | intron_variant | Intron 8 of 13 | 1 | NM_144997.7 | ENSP00000285071.4 | |||
| ENSG00000264187 | ENST00000427497.3 | n.149-2257G>A | intron_variant | Intron 4 of 11 | 1 | ENSP00000394249.3 | ||||
| FLCN | ENST00000466317.1 | n.940G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.105 AC: 15910AN: 152146Hom.: 978 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
15910
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.132 AC: 185337AN: 1400262Hom.: 13061 Cov.: 32 AF XY: 0.133 AC XY: 91591AN XY: 690966 show subpopulations
GnomAD4 exome
AF:
AC:
185337
AN:
1400262
Hom.:
Cov.:
32
AF XY:
AC XY:
91591
AN XY:
690966
show subpopulations
African (AFR)
AF:
AC:
1204
AN:
31650
American (AMR)
AF:
AC:
4696
AN:
35868
Ashkenazi Jewish (ASJ)
AF:
AC:
3885
AN:
25188
East Asian (EAS)
AF:
AC:
9
AN:
35798
South Asian (SAS)
AF:
AC:
9897
AN:
79362
European-Finnish (FIN)
AF:
AC:
5636
AN:
48358
Middle Eastern (MID)
AF:
AC:
785
AN:
5698
European-Non Finnish (NFE)
AF:
AC:
151954
AN:
1080224
Other (OTH)
AF:
AC:
7271
AN:
58116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
10176
20352
30529
40705
50881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5488
10976
16464
21952
27440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.105 AC: 15920AN: 152264Hom.: 979 Cov.: 32 AF XY: 0.105 AC XY: 7789AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
15920
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
7789
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
1794
AN:
41572
American (AMR)
AF:
AC:
1867
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
548
AN:
3472
East Asian (EAS)
AF:
AC:
6
AN:
5192
South Asian (SAS)
AF:
AC:
522
AN:
4818
European-Finnish (FIN)
AF:
AC:
1237
AN:
10612
Middle Eastern (MID)
AF:
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9492
AN:
67992
Other (OTH)
AF:
AC:
271
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
727
1454
2181
2908
3635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
157
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.